As of 2026-10-06, the Relative Valuation of Creo Medical Group PLC (CREO.L) is 33.36 GBP. This relative valuation is based on P/E multiples. With the latest stock price at 9.95 GBP, the upside of Creo Medical Group PLC based on Relative Valuation is 235.3%.
The range of the Relative Valuation is 23.59 - 34.93 GBP.
| Range | Selected | |
| Trailing P/E multiples | 23.6x - 29.3x | 27.4x |
| Forward P/E multiples | 19.8x - 29.2x | 28.6x |
| Fair Price | 23.59 - 34.93 | 33.36 |
| Upside | 137.1% - 251.1% | 235.3% |
| Date | P/E |
| 2026-10-02 | 8.17 |
| 2026-10-01 | 8.25 |
| 2026-09-30 | 8.76 |
| 2026-09-29 | 10.00 |
| 2026-09-28 | 10.01 |
| 2026-09-25 | 10.35 |
| 2026-09-24 | 10.30 |
| 2026-09-23 | 10.31 |
| 2026-09-22 | 10.32 |
| 2026-09-21 | 10.33 |
| 2026-09-18 | 10.25 |
| 2026-09-17 | 10.20 |
| 2026-09-16 | 10.41 |
| 2026-09-15 | 10.42 |
| 2026-09-14 | 10.45 |
| 2026-09-11 | 10.46 |
| 2026-09-10 | 10.51 |
| 2026-09-09 | 10.62 |
| 2026-09-08 | 10.63 |
| 2026-09-07 | 10.64 |
| 2026-09-04 | 10.88 |
| 2026-09-03 | 10.83 |
| 2026-09-02 | 10.83 |
| 2026-09-01 | 10.95 |
| 2026-08-28 | 11.09 |
| 2026-08-27 | 10.93 |
| 2026-08-26 | 10.94 |
| 2026-08-25 | 10.84 |
| 2026-08-24 | 10.85 |
| 2026-08-21 | 10.98 |
| 2026-08-20 | 10.72 |
| 2026-08-19 | 10.94 |
| 2026-08-18 | 10.74 |
| 2026-08-17 | 10.96 |
| 2026-08-14 | 10.48 |
| 2026-08-13 | 10.20 |
| 2026-08-12 | 10.41 |
| 2026-08-11 | 10.53 |
| 2026-08-10 | 10.64 |
| 2026-08-07 | 10.77 |
| 2026-08-06 | 10.72 |
| 2026-08-05 | 10.83 |
| 2026-08-04 | 11.16 |
| 2026-08-03 | 11.17 |
| 2026-07-31 | 11.19 |
| 2026-07-30 | 11.14 |
| 2026-07-29 | 11.46 |
| 2026-07-28 | 11.58 |
| 2026-07-27 | 11.59 |
| 2026-07-24 | 11.51 |